Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression
0.75 program creditsISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
Boosting Flu Vaccination Rates: A Guide for Primary Care Providers
A Practical Guide to Prescribing in HF
0.75 program creditsItching for More: Treatment Options Continue to Expand for Itch and Pain
The Clinical Use of HER2-Targeted Therapies in Gastric Cancer: The Current and Emerging Landscape
0.50 creditsISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
Definition and staging of CKM syndrome
1.00 program creditsBeyond Prevention: Examining the Lesser-Known Benefits of Flu Vaccination
Bridging the Gap: ns-MRAs in Modern Cardiorenal-Metabolic Care
1.25 credits 4 episodesNovember 16, 2024
07:00 PM - 08:30 PM CST
Pulmonary Hypertension: Diagnosis, Management, and Updates
Strategies for Integrating Flu Vaccination into Routine Patient Care
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
1.00 creditsNavigating mCRC: A Closer Look at Biomarker Testing
Comprehensive Immunization: Co-Administering Flu, RSV, and COVID-19 Vaccines
Nonsteroidal MRAs: The CKD/T2D Advantage
1.25 program creditsTailored to Fit: Precision Medicine in Metastatic CRC
The Evolving Role of MET TKIs in NSCLC
0.75 creditsArtificial Intelligence in Healthcare: 6 Strategies to Maximize Benefits While Minimizing Risk
How Is Artificial Intelligence Transforming Healthcare Administration, Documentation, and Patient Care?
Psoriasis Disparities Among Different Racial and Ethnic Groups
AI in Healthcare: How Chatbots Can Change the Way Patients Navigate Through Medical Support
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Artificial Intelligence for Cancer Detection: The Next Frontier in Oncology
Unveiling the Reperfusion Paradox
0.50 program creditsNovember 16, 2024
Chicago, Illinois
Pulmonary Hypertension: Diagnosis, Management, and Updates
Nonsteroidal MRAs: The CKD/T1D Potential
1.25 program creditsMastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
1.00 creditsThe Burden of TED
1.00 program creditsTreatment Intensification in HR+/HER2- EBC: Who and When?
1.25 program creditsPrioritizing LDL-C Reduction for Established CVD Patients in Primary Care
Evolving Erosive GERD Therapeutics: Insights into a Treatment Option with a Novel MOA
Pathophysiology of Bronchiectasis
Causes and Outcomes of Bronchiectasis Exacerbations
Helping Ensure Adequate Tissue Sampling Within the MDT
Interpreting Test Results and Making the Treatment Decision Within the MDT